Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone
- 1 May 1994
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 170 (5) , 1213-1223
- https://doi.org/10.1016/s0002-9378(13)90437-3
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal WomenAnnals of Internal Medicine, 1992
- The benefits and risks of hormone replacement therapy: An epidemiologic overviewAmerican Journal of Obstetrics and Gynecology, 1992
- Long-term consequences of estrogen and estrogen-progestin replacementCancer Causes & Control, 1992
- A Risk-Benefit Assessment of Estrogen Therapy in Postmenopausal WomenDrug Safety, 1990
- The cancer question: An overview of recent epidemiologic and retrospective dataAmerican Journal of Obstetrics and Gynecology, 1989
- Continuous estrogen/progestin therapy in menopauseAmerican Journal of Obstetrics and Gynecology, 1987
- A new combination of conjugated equine oestrogens and medroxyprogesterone for treatment of climacteric complaintsMaturitas, 1984
- Quantitative Computed Tomography of Vertebral Spongiosa: A Sensitive Method for Detecting Early Bone Loss After OophorectomyAnnals of Internal Medicine, 1982
- Endometrial Histology and Biochemistry in Climacteric Women during Oestrogen and Oestrogen/Progestogen TherapyJournal of the Royal Society of Medicine, 1979